Home » Topics » Regulatory

Regulatory
RSS

FDA expands indications for Shire's Adynovate

Dec. 28, 2016

FDA grants approval to Spinraza for treatment of spinal muscular atrophy

Dec. 27, 2016

FDA approves Rubraca and companion diagnostic for ovarian cancer

Dec. 20, 2016

BMS's Ximency receives first approval in Japan

Dec. 19, 2016

FDA approves Eucrisa for atopic dermatitis

Dec. 15, 2016

European Commission approves Ferring's Rekovelle

Dec. 14, 2016

FDA approves Avastin for platinum-sensitive ovarian cancer

Dec. 7, 2016

European Commission approves Lucentis for sixth indication

Dec. 7, 2016

FDA approves new indication for Jardiance

Dec. 5, 2016

Mochida obtains Japanese approval for Dinagest for adenomyosis

Dec. 5, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...